Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention

American Heart Journal

Volumn 151, Issue 1, 2006, Pages 146-152

  Blackman, Daniel J ^a   Pinto, Ruxandra ^a   Ross, John R ^a   Seidelin, Peter H ^a   Ing, Douglas ^a   Jackevicius, Cynthia ^a   Mackie, Karen ^a   Chan, Christopher ^a   Dzavik, Vladimir ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY STENT; CREATININE CLEARANCE; DISEASE SEVERITY; FEMALE; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK FACTORS; TREATMENT OUTCOME;

EID: 29144493383     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.03.018     Document Type: Article

References (40)

1. J.K. Kahn, B.D. Rutherford, and D.R. MacConahay Short- and long-term outcome of percutaneous coronary angioplasty in chronic dialysis patients Am Heart J 119 1990 484 489
2. L.M. Reusser, L.A. Osborn, and H.J. White Increased mortality after coronary angioplasty in patients on chronic haemodialysis Am J Cardiol 73 1994 965 967
3. F.C. Schoebel, F. Gradaus, and K. Ivens Restenosis after elective coronary balloon angioplasty in patients with end-stage renal disease: a case-control study using quantitative coronary angiography Heart 78 1997 337 342
4. H.H. Ting, N.K. Tahirkheli, and P.B. Berger Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure Am J Cardiol 87 2001 630 633
5. S.S. Naidu, F. Selzer, and A. Jacobs Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention Am J Cardiol 92 2003 1160 1164
6. P.J.M. Best, R. Lennon, and H.H. Ting The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions J Am Coll Cardiol 39 2002 1113 1119
7. M.H. Rubenstein, L.C. Harrell, and B.V. Sheynberg Are patients with renal failure good candidates for percutaneous revascularization in the new device era? Circulation 102 2000 2966 2972
8. M.H. Rubenstein, B.V. Sheynberg, and L.C. Harrell Effectiveness of and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure Am J Cardiol 87 2001 856 860
9. L. Gruberg, N.J. Weissman, and R. Waksman Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency Am J Cardiol 89 2002 54 57
10. D.N. Reddan, J.C. O'Shea, and I.J. Sarembock Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT trial) Am J Cardiol 91 2003 17 21
11. S.C. Smith Jr, J.T. Dove, and A.K. Jacobs ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) J Am Coll Cardiol 37 2001 2239i 2239lxvi
12. AHA committee report A reporting system for coronary artery disease Circulation 1975 51 55
13. C.L. Manske, Y. Wang, and T. Rector Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure Lancet 340 1992 998 1002
14. M. de Meyer, W. Wyns, and R. Dion Myocardial revascularization in patients on renal replacement therapy Clin Nephrol 36 1991 147 151
15. D.N. Reddan Therapy for cardiovascular disease in patients with chronic kidney disease: appropriate caution or the absence of data Am Heart J 144 2002 206 207
16. M. Tonelli, C. Bohm, and S. Pandeya Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency Am J Kidney Dis 37 2001 484 489
17. S.A. Simsir, D. Kohlman-Trigoboff, and R. Flood A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on haemodialysis Cardiovasc Surg 6 1998 500 505
18. L.A. Szczech, D.N. Reddan, and W.F. Owen Differential survival after coronary revascularization procedures among patients with renal insufficiency Kidney Int 60 2001 292 299
19. T. Koyanagi, H. Nishida, and M. Kitamura Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients Ann Thorac Surg 61 1996 1793 1796
20. A.L. Rinehart, C.A. Herzog, and A.J. Collins A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients Am J Kidney Dis 25 1995 281 290
21. L. Labrousse, C. de Vincentiis, and F. Madonna Early and long-term results of coronary artery bypass grafts in patients with dialysis dependent renal failure Eur J Cardiothorac Surg 15 1999 691 696
22. S.G. Rostand, K.A. Kirk, and E.A. Rutsky Results of coronary artery bypass grafting in end-stage renal disease Am J Kidney Dis 12 1988 266 270
23. T.D. Batiuk, S.B. Kurtz, and J.K. Oh Coronary artery bypass operation in dialysis patients Mayo Clin Proc 66 1991 45 53
24. R.J. Anderson, M. O'Brien, and S. MaWhinney Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. VA Cooperative Study #5 Kidney Int 55 1999 1057 1062
25. B. Frilling, R. Zahn, and B. Fraiture Comparison of efficacy and complication rates after percutaneous coronary intervention in patients with and without renal insufficiency treated with abciximab Am J Cardiol 89 2002 450 452
26. S. Ellis, M. Vandormael, and M. Cowley Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection: Multivessel Angioplasty Prognosis Study Group Circulation 82 1990 1193 1202
27. M.C. Thel, R.M. Califf, and J.E. Tcheng Clinical risk factors for ischaemic complications after percutaneous coronary interventions: results from the EPIC trial: the Epic investigators Am Heart J 137 1999 267 273
28. K. Amann, and R. Veelken Mechanisms and consequences of sympathetic hyperactivity in renal disease Clin Nephrol 60 2003 S81 S92
29. Herzog CA, Strief J, Gilbertson D, et al. Cause-specific mortality of dialysis patients after coronary revascularization: why don't dialysis patients have better survival after coronary intervention? Renal week. American Society of Nephrology 2004. Washington DC (Abstract).
30. R.G. Luke Chronic renal failure: a vasculopathic state N Engl J Med 339 1998 841 843
31. B.N. Becker, J. Himmelfarb, and W.L. Henrich Reassessing the cardiac risk actor profile in chronic haemodialysis patients: a hypothesis on the role of oxidative stress and other non-traditional cardiac risk factors J Am Soc Nephrol 8 1997 75 86
32. P.O. Attmann, and P. Alaupovic Abnormalities of lipoprotein composition in renal insufficiency Prog Lipid Res 30 1991 275 279
33. A.M. Romanic, A.J. Arleth, and R.N. Willette Factor XIIIa cross-links lipoprotein (a) with fibrinogen and is present in human atherosclerotic lesions Circ Res 83 1998 264 269
34. D. Flier, G. Pacini, and R. Engelleiter Insulin resistance and hyperinsulinaemia are already present in patients with incipient renal disease Kidney Int 53 1998 1343 1347
35. P. Jungers, D. Joly, and Z. Massy Sustained reduction of hyperhomocystinaemia with folic acid supplementation in predialysis patients Nephrol Dial Transplant 14 1999 2903 2906
36. P.A. McCullough, R. Wolyn, and L.L. Rocher Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 1997 368 375
37. R. Solomon, C. Werner, and D. Mann Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents N Engl J Med 343 2000 180 184
38. B.J. Barrett, and E.J. Carlisle Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 188 1993 171 178
39. R. Birck, S. Krzossok, and F. Markowetz Acetylcysteine for prevention of contrast nephropathy: meta-analysis Lancet 362 2003 598 603
40. G. Manjunath, H. Tighiuoart, and H. Ibrahim Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community J Am Coll Cardiol 41 2003 47 55